Clinical trial
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
NCT02390531 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
- Lead sponsor
- Jaeb Center for Health Research
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 28, 2015
- Completion date
- May 11, 2021
- Enrollment
- 120 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.